TNFAIP2 and neoplasm: TNFAIP2 is abnormally highly expressed in a variety of tumor cells, including TNBC (Jia et al., 2016), nasopharyngeal carcinoma (Chen et al., 2011), malignant glioma (Cheng et al., 2015), uroepithelial carcinoma (Niwa et al., 2019), and esophageal squamous cell carcinoma (Xie and Wang, 2017), and is associated with poor prognosis.